Loading clinical trials...
Loading clinical trials...
The goal of the proposed study is to identify PVP-I at 1.25% as an appropriate intranasal topical preparation for patients undergoing rhinoplasty with no effect on the nasal mucosa cilia (NMC) or olfa...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Boston Medical Center
NCT07531810 · Nasal Deformity, Rhinoplasty, and more
NCT07317947 · Rhinoplasty, Nasal Surgery, and more
NCT03925389 · Rhinoplasty, Nasal Obstruction, and more
NCT05964868 · Rhinoplasty, Pain Management
NCT06649370 · Rhinoplasty
Boston Medical Center
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions